CORT · Corcept Therapeutics Inc
$113.88
-3.05 (-2.61%)
At close · Aug 28
Market Cap
$12.31B
Shares
108.10M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-07-29 | 2026-06-30 | |
| 8-K | 2026-07-29 | — | |
| 8-K | 2026-06-17 | — | |
| 8-K | 2026-06-03 | 2026-05-19 | |
| 8-K | 2026-05-28 | 2026-05-21 | |
| 10-Q | 2026-04-30 | 2026-03-31 | |
| 8-K | 2026-04-30 | — | |
| DEF 14A | 2026-04-17 | — | |
| 8-K | 2026-03-25 | — | |
| 10-K | 2026-02-24 | 2025-12-31 | |
| 8-K | 2026-02-24 | — | |
| 8-K | 2026-02-19 | — | |
| 8-K | 2026-01-22 | — | |
| 8-K | 2025-12-31 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-10-14 | 2025-10-10 | |
| 8-K | 2025-10-06 | — | |
| 8-K | 2025-09-10 | — | |
| 10-Q | 2025-07-31 | 2025-06-30 | |
| 8-K | 2025-07-31 | — | |
| 8-K | 2025-07-14 | — | |
| 8-K | 2025-06-16 | 2025-06-10 | |
| 10-Q | 2025-05-05 | 2025-03-31 | |
| 8-K | 2025-05-05 | — | |
| DEF 14A | 2025-04-25 | — | |
| 8-K | 2025-03-31 | — | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2025-02-26 | — | |
| 10-K | 2025-02-26 | 2024-12-31 | |
| 8-K | 2024-12-30 | — | |
| 8-K | 2024-10-30 | — | |
| 10-Q | 2024-10-30 | 2024-09-30 | |
| 8-K | 2024-07-29 | — | |
| 10-Q | 2024-07-29 | 2024-06-30 | |
| 8-K | 2024-05-23 | 2024-05-17 | |
| 8-K | 2024-05-01 | — | |
| 10-Q | 2024-05-01 | 2024-03-31 | |
| 8-K | 2024-04-17 | 2024-04-12 | |
| DEF 14A | 2024-04-10 | — | |
| 8-K | 2024-02-15 | — | |
| 10-K | 2024-02-15 | 2023-12-31 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2024-01-02 | — | |
| 8-K | 2023-12-11 | 2023-12-05 | |
| 10-Q | 2023-11-01 | 2023-09-30 | |
| 8-K | 2023-11-01 | — | |
| 8-K | 2023-08-02 | — | |
| 10-Q | 2023-08-02 | 2023-06-30 | |
| 8-K | 2023-05-24 | 2023-05-19 |
Showing 1–50 of 101 filings
Key facts
CIK
1088856
CUSIP
218352102
13F (30d)
327 filings
317 filers
Visit website
Investor relations